Patent · US Active

Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators

US7763607B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignee

Solvay Pharmaceuticals, GmbH · US

Inventors

Jochen Antel · Annaberg-Buchholz, DE
Peter-Colin Gregory · Hannover, DE
Josephus Hubertus Maria Lange · Almere, NL
Michael Firnges · Barsinghausen, DE
Dania Birte REICHE · Bingen, DE

Key dates

Filing date	Apr 26, 2007
Grant date	Jul 27, 2010
Priority date	—
Expiry date	Apr 26, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are pharmaceutical compositions comprising therapeutically effective quantities of (i) a KATP channel modulator; and (ii) a CBx modulator. Also described herein are methods of making and using these compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.